Literature DB >> 6970232

Biophysical characterization of normal T-lymphocytes and Sézary cells.

E C Vonderheid, S M Fang, M K Helfrich, S R Abraham, C A Nicolini.   

Abstract

Blood lymphocytes from 18 patients with cutaneous T-cell lymphoma (Sézary syndrome and mycosis fungoides) were characterized using multiparameter laser flow microfluorimetry (FMF) and automated image analysis (AIA) and the results correlated with routine blood smears, cytogenetic studies and observations made on PHA-stimulated normal T-lymphocytes in vitro. Specimens from all 9 patients with Sézary syndrome and 5 of 9 patients with mycosis fungoides contained one or more discrete subpopulations of neoplastic (Sézary) lymphocytes that were detected by FMF. Studies with AIA demonstrated that neoplastic T-lymphocytes are distinguished from normal quiescent (G0) lymphocytes not only by alterations in DNA content (aneuploidy) but also by chromatin structuring (increased chromatin dispersion), which may be a more sensitive index of neoplastic transformation than ploidy levels. In several patients, small and large Sézary cells were present with DNA-chromatin properties quite similar to normal cycling G1 and G2 lymphocytes respectively, but their presence was not explained by an increase in proliferative activity in the blood. These findings indicate that Sézary syndrome consists of a heterogeneous group of related disorders differing in terms of the Sézary cell population. The response to treatment and prognosis may differ accordingly.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6970232     DOI: 10.1111/1523-1747.ep12524497

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  1 in total

1.  Activated and cycling lymphocytes in benign dermal lymphocytic infiltrates including psoriatic skin lesions.

Authors:  G Lange Wantzin; J K Larsen; I J Christensen; E Ralfkiaer; M Tjalve; M Lund Kofoed; K Thomsen
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.